Literature DB >> 35989593

Number Needed to Quarantine and Proportion of Prevented Infectious Days by Quarantine: Evaluating the Effectiveness of COVID-19 Contact Tracing.

Diogo Fernandes da Silva1, João Vasco Santos1,2,3, Filipa Santos Martins1.   

Abstract

OBJECTIVES: Information on the effectiveness of COVID-19 contact tracing is lacking. We proposed 2 measures for evaluating the effectiveness of contact tracing and applied them in a public health unit in northern Portugal.
METHODS: This retrospective cohort study included the contacts of people with COVID-19 diagnosed July 1-September 15, 2020. We examined 2 measures: (1) number needed to quarantine (NNQ), as the number of quarantine person-days needed to prevent 1 potential infectious person-day; and (2) proportion of prevented infectious days by quarantine (PPID), as the number of potential infectious days prevented by quarantine divided by all infectious days. We assessed these measures by sociodemographic characteristics, types of contacts, and intervention timings (ie, time between diagnosis or symptom onset and intervention). We considered 3 scenarios for infectiousness periods: 10 days before to 10 days after symptom onset, 3 days before to 3 days after symptom onset, and 2 days before to 10 days after symptom onset.
RESULTS: We found an NNQ of 19.8-41.8 person-days and a PPID of 19.7%-38.2%, depending on the infectiousness period scenario. Effectiveness was higher among cohabitants and symptomatic contacts than among social or asymptomatic contacts. NNQ and PPID changed by intervention timings: the effectiveness of contact tracing decreased with time from diagnosis to quarantine of contacts and with time from symptom onset of the index case to contacts' quarantine.
CONCLUSIONS: These proposed measures of contact tracing effectiveness of communicable diseases can be important for decision making and prioritizing contact tracing when resources are scarce. They are also useful measures for communication with the general population, policy makers, and clinicians because they are easy to understand and use to assess the impact of health interventions.

Entities:  

Keywords:  COVID-19; Portugal; contact tracing; effectiveness; number needed to quarantine; public health

Mesh:

Year:  2022        PMID: 35989593      PMCID: PMC9548448          DOI: 10.1177/00333549221114343

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   3.117


  29 in total

1.  NNT, number needed to treat: does it have any real value?

Authors:  A Pines; S Shapiro; S Suissa
Journal:  Climacteric       Date:  2012-01-28       Impact factor: 3.005

Review 2.  How and why researchers use the number needed to vaccinate to inform decision making--a systematic review.

Authors:  Ahmed Hashim; Vica Dang; Shelly Bolotin; Natasha S Crowcroft
Journal:  Vaccine       Date:  2014-12-25       Impact factor: 3.641

3.  An assessment of clinically useful measures of the consequences of treatment.

Authors:  A Laupacis; D L Sackett; R S Roberts
Journal:  N Engl J Med       Date:  1988-06-30       Impact factor: 91.245

4.  Childhood influenza: number needed to vaccinate to prevent 1 hospitalization or outpatient visit.

Authors:  Elizabeth N Lewis; Marie R Griffin; Peter G Szilagyi; Yuwei Zhu; Kathryn M Edwards; Katherine A Poehling
Journal:  Pediatrics       Date:  2007-09       Impact factor: 7.124

5.  The effectiveness of contact tracing in emerging epidemics.

Authors:  Don Klinkenberg; Christophe Fraser; Hans Heesterbeek
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

6.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

7.  Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis.

Authors:  Yousef Alimohamadi; Mojtaba Sepandi; Maryam Taghdir; Hadiseh Hosamirudsari
Journal:  J Prev Med Hyg       Date:  2020-10-06

8.  Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing.

Authors:  Luca Ferretti; Chris Wymant; David Bonsall; Christophe Fraser; Michelle Kendall; Lele Zhao; Anel Nurtay; Lucie Abeler-Dörner; Michael Parker
Journal:  Science       Date:  2020-03-31       Impact factor: 47.728

9.  Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020.

Authors:  Tapiwa Ganyani; Cécile Kremer; Dongxuan Chen; Andrea Torneri; Christel Faes; Jacco Wallinga; Niel Hens
Journal:  Euro Surveill       Date:  2020-04

10.  SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease.

Authors:  Ranawaka A P M Perera; Eugene Tso; Owen T Y Tsang; Dominic N C Tsang; Kitty Fung; Yonna W Y Leung; Alex W H Chin; Daniel K W Chu; Samuel M S Cheng; Leo L M Poon; Vivien W M Chuang; Malik Peiris
Journal:  Emerg Infect Dis       Date:  2020-08-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.